Plasma and/or bronchoalveolar levels of IL-6 have been identified as early biomarkers of lung injury and predictive factors of prolonged mechanical ventilation, organ dysfunctions, morbidity, and mortality in lung diseases (17, 18). This evidence concerns the gene IL6 and lung disorder.